# PROCTER & GAMBLE Co (PG)

Informational only - not investment advice.

CIK: 0000080424
SIC: 2840 Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
SIC breadcrumb: [Manufacturing](/division/D/) > [Chemicals And Allied Products](/major-group/28/) > [SIC 2840 Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics](/industry/2840/)
Latest 10-K filed: 2026-08-04
SEC page: https://www.sec.gov/edgar/browse/?CIK=80424
Filing source: https://www.sec.gov/Archives/edgar/data/80424/000008042426000103/pg-20260630.htm

## At a glance

FY2026 · period end 2026-06-30 · filed 2026-08-04 · accession 0000080424-26-000103 · source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000080424.json

| Metric | Value | FY | Provenance |
| --- | ---: | ---: | --- |
| Revenue | 87,032,000,000 USD | 2026 | verified |
| Net income | 16,046,000,000 USD | 2026 | verified |
| Assets | 126,521,000,000 USD | 2026 | verified |
| Free cash flow | 15,147,000,000 USD | 2026 | computed |
| Net margin | 18.44% | 2026 | computed |
| Operating margin | 22.69% | 2026 | computed |
| Revenue YoY | +3.26% | 2026 | computed |
| ROE | 29.54% | 2026 | computed |

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2026 revenue ÷ FY2025 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

### Peer percentile fingerprint

| Ratio | PG | Peer median | Percentile | N |
| --- | ---: | ---: | ---: | ---: |
| Net margin | 18.4% | 1.2% | 82 | 219 |
| Operating margin | 22.7% | 3.0% | 84 | 201 |
| Revenue growth | 3.3% | 8.0% | 42 | 251 |
| FCF margin | 17.4% | -1.7% | 80 | 251 |
| ROE | 29.5% | -23.2% | 91 | 314 |
| ROA | 12.7% | -12.1% | 89 | 340 |
| Liabilities / equity | 1.33 | 0.61 | 69 | 319 |
| Current ratio | 0.68 | 3.93 | 1 | 341 |

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 28 Chemicals And Allied Products, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

## Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
| --- | ---: | --- | ---: | --- |
| Revenue | 87032000000 | USD | 2026 | 2026-08-04 |
| Net income | 16046000000 | USD | 2026 | 2026-08-04 |
| Assets | 126521000000 | USD | 2026 | 2026-08-04 |

## Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-04. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000080424.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | 65,058,000,000 | 66,832,000,000 | 67,684,000,000 | 70,950,000,000 | 76,118,000,000 | 80,187,000,000 | 82,006,000,000 | 84,039,000,000 | 84,284,000,000 | 87,032,000,000 |
| Net income | 15,326,000,000 | 9,750,000,000 | 3,897,000,000 | 13,027,000,000 | 14,306,000,000 | 14,742,000,000 | 14,653,000,000 | 14,879,000,000 | 15,974,000,000 | 16,046,000,000 |
| Operating income | 13,766,000,000 | 13,363,000,000 | 5,487,000,000 | 15,706,000,000 | 17,986,000,000 | 17,813,000,000 | 18,134,000,000 | 18,545,000,000 | 20,451,000,000 | 19,748,000,000 |
| Diluted EPS | 5.59 | 3.67 | 1.43 | 4.96 | 5.50 | 5.81 | 5.90 | 6.02 | 6.51 | 6.62 |
| Operating cash flow | 12,753,000,000 | 14,867,000,000 | 15,242,000,000 | 17,403,000,000 | 18,371,000,000 | 16,723,000,000 | 16,848,000,000 | 19,846,000,000 | 17,817,000,000 | 19,556,000,000 |
| Capital expenditures | 3,384,000,000 | 3,717,000,000 | 3,347,000,000 | 3,073,000,000 | 2,787,000,000 | 3,156,000,000 | 3,062,000,000 | 3,322,000,000 | 3,773,000,000 | 4,409,000,000 |
| Dividends paid | 7,236,000,000 | 7,310,000,000 | 7,498,000,000 | 7,789,000,000 | 8,263,000,000 | 8,770,000,000 | 8,999,000,000 | 9,312,000,000 | 9,872,000,000 | 10,232,000,000 |
| Share buybacks | 5,204,000,000 | 7,004,000,000 | 5,003,000,000 | 7,405,000,000 | 11,009,000,000 | 10,003,000,000 | 7,353,000,000 | 5,006,000,000 | 6,500,000,000 | 5,028,000,000 |
| Assets | 120,406,000,000 | 118,310,000,000 | 115,095,000,000 | 120,700,000,000 | 119,307,000,000 | 117,208,000,000 | 120,829,000,000 | 122,370,000,000 | 125,231,000,000 | 126,521,000,000 |
| Liabilities | 64,628,000,000 | 65,427,000,000 | 67,516,000,000 | 73,822,000,000 | 72,653,000,000 | 70,354,000,000 | 73,764,000,000 | 71,811,000,000 | 72,946,000,000 | 72,210,000,000 |
| Stockholders' equity | 55,778,000,000 | 52,883,000,000 | 47,579,000,000 | 46,878,000,000 | 46,654,000,000 | 46,854,000,000 | 47,065,000,000 | 50,559,000,000 | 52,284,000,000 | 54,311,000,000 |
| Free cash flow | 9,369,000,000 | 11,150,000,000 | 11,895,000,000 | 14,330,000,000 | 15,584,000,000 | 13,567,000,000 | 13,786,000,000 | 16,524,000,000 | 14,044,000,000 | 15,147,000,000 |

### Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net margin | 23.56% | 14.59% | 5.76% | 18.36% | 18.79% | 18.38% | 17.87% | 17.70% | 18.95% | 18.44% |
| Operating margin | 21.16% | 19.99% | 8.11% | 22.14% | 23.63% | 22.21% | 22.11% | 22.07% | 24.26% | 22.69% |
| Return on equity | 27.48% | 18.44% | 8.19% | 27.79% | 30.66% | 31.46% | 31.13% | 29.43% | 30.55% | 29.54% |
| Return on assets | 12.73% | 8.24% | 3.39% | 10.79% | 11.99% | 12.58% | 12.13% | 12.16% | 12.76% | 12.68% |
| Liabilities / equity | 1.16 | 1.24 | 1.42 | 1.57 | 1.56 | 1.50 | 1.57 | 1.42 | 1.40 | 1.33 |
| Current ratio | 0.88 | 0.83 | 0.75 | 0.85 | 0.70 | 0.65 | 0.63 | 0.73 | 0.70 | 0.68 |

## As-reported value updates

2 tracked differences above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period.

Ledger: /company/PG/revisions/


## Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-04. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000080424.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

| Quarter | End date | Revenue | Net income | Diluted EPS | Method |
| --- | --- | ---: | ---: | ---: | --- |
| 2023-Q1 | 2022-09-30 |  |  | 1.57 | reported discrete quarter |
| 2023-Q2 | 2022-12-31 |  |  | 1.59 | reported discrete quarter |
| 2023-Q3 | 2023-03-31 |  |  | 1.37 | reported discrete quarter |
| 2024-Q1 | 2023-09-30 | 21,871,000,000 | 4,521,000,000 | 1.83 | reported discrete quarter |
| 2024-Q2 | 2023-12-31 | 21,441,000,000 | 3,468,000,000 | 1.40 | reported discrete quarter |
| 2024-Q3 | 2024-03-31 | 20,195,000,000 | 3,754,000,000 | 1.52 | reported discrete quarter |
| 2024-Q4 | 2024-06-30 | 20,532,000,000 | 3,137,000,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2025-Q1 | 2024-09-30 | 21,737,000,000 | 3,959,000,000 | 1.61 | reported discrete quarter |
| 2025-Q2 | 2024-12-31 | 21,882,000,000 | 4,630,000,000 | 1.88 | reported discrete quarter |
| 2025-Q3 | 2025-03-31 | 19,776,000,000 | 3,769,000,000 | 1.54 | reported discrete quarter |
| 2025-Q4 | 2025-06-30 | 20,889,000,000 | 3,615,000,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2026-Q1 | 2025-09-30 | 22,386,000,000 | 4,750,000,000 | 1.95 | reported discrete quarter |
| 2026-Q2 | 2025-12-31 | 22,208,000,000 | 4,319,000,000 | 1.78 | reported discrete quarter |
| 2026-Q3 | 2026-03-31 | 21,235,000,000 | 3,932,000,000 | 1.63 | reported discrete quarter |
| 2026-Q4 | 2026-06-30 | 21,204,000,000 | 3,044,000,000 |  | derived Q4 = FY annual - nine-month YTD |

## Filed narrative (10-K & 10-Q)

## Business

Verbatim Item 1 Business section from PG's latest 10-K: [/company/PG/business/](/company/PG/business/).

## Risk Factors

Verbatim Item 1A Risk Factors from PG's latest 10-K: [/company/PG/risk-factors/](/company/PG/risk-factors/).

## Latest quarter (10-Q)

Latest 10-Q source: https://www.sec.gov/Archives/edgar/data/80424/000008042426000060/pg-20260331.htm

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary.
Confidence: high
Filing date: 2026-04-24
Report date: 2026-03-31

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, in the following sections: “Management's Discussion and Analysis,” “Risk Factors” and "Notes 4 and 9 to the Consolidated Financial Statements." These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.

Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, changes in global interest rates and rate differentials, currency exchange, or pricing controls and tariffs; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to successfully manage uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market contraction, boycotts, variability and unpredictability in trade relations, sanctions, tariffs or other trade controls; (4) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (5) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, conflicts or acts of war (such as the conflict in the Middle East), terrorism or disease outbreaks; (6) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pensions and healthcare; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices, social or environmental practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business

Amounts in millions of dollars except per share amounts or as otherwise specified.

The Procter & Gamble Company 15

partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns; (13) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (14) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (16) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws, regulations, policies and related interpretations involving product liability, product and packaging composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy, cybersecurity, data protection and data transfers, artificial intelligence, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (17) the ability to manage changes in applicable tax laws and regulations; and (18) the ability to continue delivering progress towards our environmental sustainability ambitions. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from those projected herein is included in the section titled "Economic Conditions and Uncertainties" and the section titled "Risk Factors" (Part II, Item 1A) of this Form 10-Q.

Purpose, Approach and Non-GAAP Measures

The purpose of Management's Discussion and Analysis (MD&A) is to provide an understanding of Procter & Gamble's financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. The MD&A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and accompanying Notes.

The MD&A is organized in the following sections:

•Overview

•Recent Developments

•Summary of Results – Nine Months Ended March 31, 2026

•Economic Conditions and Uncertainties

•Results of Operations – Three and Nine Months Ended March 31, 2026

•Segment Results – Three and Nine Months Ended March 31, 2026

•Liquidity and Capital Resources

•Measures Not Defined by U.S. GAAP

Throughout the MD&A we refer to measures used by management to evaluate performance, including unit volume growth, net sales, net earnings, diluted net earnings per common share (diluted EPS) and operating cash flow. We also refer to a number of financial measures that are not defined under U.S. GAAP, consisting of organic sales growth, Core earnings per share (Core EPS), adjusted free cash flow and adjusted free cash flow productivity. The explanation at the end of the MD&A provides the definition of these non-GAAP measures, details on the use and the derivation of these measures, as well as reconciliations to the most directly comparable U.S. GAAP measure.

Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share and consumption information. References to market share and consumption in the MD&A are based on a combination of vendor-purchased traditional brick-and-mortar and online data in key markets as well as internal estimates. All market share references represent the percentage of sales of our products in dollar terms on a constant currency basis relative to all product sales in the category. The Company measures quarter and fiscal year to date market share through the most recent period for which market share data is available, which typically reflects a lag time of one or two months as compared to the end of the reporting period. Management also uses unit volume growth to evaluate drivers of changes in net sales. Organic volume growth reflects year-over-year changes in unit volume excluding the impacts of acquisitions and divestitures and certain one-time items, if applicable, and is used to explain changes in organic sales. In the presentation of data in tables or other charts, certain columns and rows may not add due to rounding.

OVERVIEW

P&G is a global leader in the fast-moving consumer goods industry, focused on providing branded consumer packaged goods of superior quality and value to our consumers around the world. Our products are sold in about 180 countries and territories, primarily through mass merchandisers, e-commerce (including social commerce) channels, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores (including airport duty-free stores),

16 The Procter & Gamble Company

high-frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to individual consumers. We have on-the-ground operations in about 70 countries.

Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands. Additionally, many of the product segments in which we compete are differentiated by price tiers (referred to as super-premium, premium, mid-tier and value-tier products). We believe we are well positioned in the industry segments and markets in which we operate, often holding a leadership or significant market share position.

The table below lists our reportable segments, including the product categories and brand composition within each segment.

[Excerpt truncated for page length; source filing is linked above.]

## Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: https://www.sec.gov/Archives/edgar/data/80424/000008042426000103/pg-20260630.htm
Complete FY 2026 MD&A: /company/PG/mda/fy2026/

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary.
Confidence: high
Filing date: 2026-08-04
Report date: 2026-06-30

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, in the following sections: “Management's Discussion and Analysis,” “Risk Factors” and "Notes 4, 8 and 13 to the Consolidated Financial Statements." These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.

14 The Procter & Gamble Company

Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, changes in global interest rates and rate differentials, currency exchange or pricing controls and tariffs; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to successfully manage uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market contraction, boycotts, variability and unpredictability in trade relations, sanctions, tariffs or other trade controls; (4) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (5) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, conflicts or acts of war, terrorism or disease outbreaks; (6) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pensions and healthcare; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, cyber incidents, supply chain practices, social or environmental practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage demand, supply and operational challenges; (13) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving and more fragmented digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (14) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (16) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws, regulations, policies and related interpretations involving product liability, product and packaging composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy, cybersecurity, data protection and data transfers, artificial intelligence, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (17) the ability to manage changes in applicable tax laws and regulations; and (18) the ability to continue delivering progress towards our environmental sustainability ambitions. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from those projected herein is included in the section titled "Economic Conditions and Uncertainties" and the section titled "Risk Factors" (Part I, Item 1A) of this Form 10-K.

Purpose, Approach and Non-GAAP Measures

The purpose of Management's Discussion and Analysis (MD&A) is to provide an understanding of Procter & Gamble's financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. The MD&A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and accompanying Notes. The MD&A is organized in the following sections:

•Overview

•Summary of 2026 Results

•Economic Conditions and Uncertainties

•Results of Operations

•Segment Results

•Cash Flow, Financial Condition and Liquidity

•Critical Accounting Policies and Estimates

•Other Information

Throughout the MD&A we refer to measures used by management to evaluate performance, including unit volume growth, net sales, net earnings, diluted net earnings per common share (diluted EPS) and operating cash flow. We also refer to a number of financial measures that are not defined under U.S. GAAP, including organic sales growth, Core earnings per share (Core EPS), adjusted free cash flow and adjusted free cash flow productivity. The explanation at the end of the MD&A provides the definition of these non-GAAP measures, details on the use and the derivation of these measures, as well as reconciliations to the most directly comparable U.S. GAAP measure.

The Procter & Gamble Company 15

Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share and consumption information. References to market share and consumption in the MD&A are based on a combination of vendor-purchased traditional brick-and-mortar and online data in key markets as well as internal estimates. All market share references represent the percentage of sales of our products in dollar terms on a constant currency basis relative to all product sales in the category. The Company measures market shares through the most recent period for which market share data is available, which typically reflects a lag time of one or two months as compared to the end of the reporting period. Management also uses unit volume growth to evaluate drivers of changes in net sales. Organic volume growth reflects year-over-year changes in unit volume excluding the impacts of acquisitions and divestitures and certain one-time items, if applicable, and is used to explain changes in organic sales. In our presentation of data in tables or other charts, certain columns and rows may not add due to rounding.

OVERVIEW

P&G is a global leader in the fast-moving consumer goods industry, focused on providing branded consumer packaged goods of superior quality and value to our consumers around the world. Our products are sold in about 180 countries and territories primarily through mass merchandisers, digital commerce (including social commerce) channels, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores (including airport duty-free stores), high-frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to consumers. We have on-the-ground operations in approximately 65 countries.

Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands. Additionally, many of the product segments in which we compete are differentiated by price tiers (referred to as super-premium, premium, mid-tier and value-tier products). We believe we are well positioned in the industry segments and markets in which we operate, often holding a leadership or significant market share position.

Organizational Structure

Our organizational structure is comprised of Sector Business Units (SBUs), Enterprise Markets (EMs), Corporate Functions (CF) and Global Business Services (GBS).

Sector Business Units

The Company's product categories are organized into five SBUs and five reportable segments (under U.S. GAAP): Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The SBUs are responsible for global brand strategy, product upgrades and innovation, marketing plans and supply chain. They have direct profit responsibility for markets (referred to as Focus Markets) representing the large majority of the Company's sales and earnings and are also responsible for innovation plans, supply plans and operating frameworks to drive growth and value creation in the remaining markets (referred to as Enterprise Markets). Throughout the MD&A, we reference business results by region, which are comprised of North America, Europe, Greater China, Latin America, Asia Pacific and India, Middle East and Africa (IMEA).

16 The Procter & Gamble Company

The following provides additional detail on our reportable segments and the product categories and brand composition within each segment.

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2026 MD&A: /company/PG/mda/fy2026/
All MD&A years: /company/PG/mda/


## MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

- [FY 2025 MD&A](/company/PG/mda/fy2025/): filed 2025-08-04; accession 0000080424-25-000076 (https://www.sec.gov/Archives/edgar/data/80424/000008042425000076/pg-20250630.htm)
- [FY 2024 MD&A](/company/PG/mda/fy2024/): filed 2024-08-05; accession 0000080424-24-000083 (https://www.sec.gov/Archives/edgar/data/80424/000008042424000083/pg-20240630.htm)
- [FY 2023 MD&A](/company/PG/mda/fy2023/): filed 2023-08-04; accession 0000080424-23-000073 (https://www.sec.gov/Archives/edgar/data/80424/000008042423000073/pg-20230630.htm)
- [FY 2022 MD&A](/company/PG/mda/fy2022/): filed 2022-08-05; accession 0000080424-22-000064 (https://www.sec.gov/Archives/edgar/data/80424/000008042422000064/pg-20220630.htm)




## Macro cross-references

Indicators mapped to this company's SIC classification (industry 2840 Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

- [INDPRO](/indicator/INDPRO/): Industrial Production: Total Index
- [TCU](/indicator/TCU/): Capacity Utilization: Total Index
- [PPIACO](/indicator/PPIACO/): Producer Price Index by Commodity: All Commodities
- [GDPC1](/indicator/GDPC1/): Real Gross Domestic Product
- [DGS10](/indicator/DGS10/): Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity
- [FEDFUNDS](/indicator/FEDFUNDS/): Federal Funds Effective Rate
- [CES0500000003](/indicator/CES0500000003/): Average Hourly Earnings of All Employees, Total Private
- [PAYEMS](/indicator/PAYEMS/): All Employees, Total Nonfarm

Macro-to-micro threads including this sector: [Inflation (CPI / PCE / PPI)](/thread/inflation-cpi-pce-ppi/), [US labor market](/thread/us-labor-market/), [Growth & output](/thread/growth-output/), [Money & trade](/thread/money-trade/), [Government finances](/thread/government-finances/), [Sector employment](/thread/sector-employment/), [Industrial orders & inventories](/thread/industrial-orders/), [Trade & external](/thread/trade-external/).

All macro indicators: /indicators/


## For LLMs & downloads

Markdown twin: /company/PG.md · JSON record: /company/PG.json · verified financials: /company/PG/financials.json / /company/PG/financials.csv · machine TOC for the whole site: /llms.txt